"As psychiatric diagnoses continue to be hotly debated, the Fourth Edition of this mainstay volume reminds the field of our deeper understanding of the neurobiological underpinnings of the brain, just a decade after the first Edition was published. This completely revamped Edition highlights articles by leaders in the fields of psychiatry and neuroscience and offers intelligent insights into how neuroscience may impact how we will diagnose and treat individuals suffering from mental illness in the very near future. The book continues to be a tour de force."
-- Dilip V. Jeste, M.D., Estelle and Edgar Levi Chair in Aging, Director, Sam and Rose Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences
University of California, San Diego
President, American Psychiatric Association, 2012
"The editors have compiled an outstanding and comprehensive overview of the biological basis of mental illness including detailed descriptions of state-of-the-art molecular, cellular, and circuit methodologies in animals and people that will lead the field to improved diagnostic tests and treatments for these debilitating conditions. This book is an important resource for those interested in entering the field as well as for accomplished researchers and practitioners."
-- Arvid Carlsson, MD, PhD, Nobel Laureate in Physiology or Medicine, 2000
"This book continues to be an outstanding testament to the effort made towards fundamental understanding of psychiatric disorders. The fourth edition is an excellent and complete update on the biological basis of psychiatric disorders. Every psychiatrist should read and refer this book." -- Doody's
About the Author
Dennis S. Charney, MD is Dean at the Icahn School of Medicine at Mount Sinai, Executive Vice President for Academic Affairs, The Mount Sinai Medical Center, and Anne and Joel Ehrenkranz Professor in the Departments of Psychiatry, Neuroscience, and Pharmacology & Systems Therapeutics at the Icahn School of Medicine at Mount Sinai in New York, NY. He is a world expert in the neurobiology and treatment of mood and anxiety disorders. He has made fundamental contributions to the understanding of neural circuits and neurochemistry related to human anxiety, fear, mood and discovery of new treatment for mood and anxiety disorders. He later expanded this area into pioneering research related to the psychobiological mechanisms of human resilience to stress. His work has been carried out over two decades at Yale University School of Medicine, and during four years at the National Institute of Mental Health (NIMH). It continues today at the Icahn School of Medicine at Mount Sinai.
Joseph D. Buxbaum, PhD, is a Professor of Psychiatry, Neuroscience, and Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, where he is also director of the Seaver Autism Center for Research and Treatment. He is a world-renowned molecular geneticist and spearheads research into human psychiatric and neurological diseases. As Vice Chair for Research in Psychiatry, Dr. Buxbaum helps set the research direction for the Department, which is ranked among the top 20 psychiatry departments in the country in NIH funding.
Pamela Sklar, MD, received her BA from St. John's College and her MD and PhD from Johns Hopkins School of Medicine and Neuroscience. She is a neuroscientist, human geneticist and clinical psychiatrist investigating the genetic causes of psychiatric disorders, including schizophrenia and bipolar disorder. A major focus of her prior work has been to identify susceptibility genes for psychiatric diseases by applying tools developed for understanding and characterizing human sequence variation. Currently, she is Chief of the Division of Psychiatric Genomics, and Professor of Psychiatry, Neuroscience, Genetics and Genomic Sciences.
Eric J. Nestler, MD, PhD, received his BA, MD, and PhD degrees from Yale University. He then served on the Yale faculty, where he was named the Elizabeth Mears and House Jameson Professor of Psychiatry of Neurobiology and Director of the Abraham Ribicoff Research Facilities. In 2000, Dr. Nestler was named the McGinley Professor of Psychiatry and Chairman of the Department of Psychiatry at the University of Texas Southwestern Medical Center at Dallas, before accepting his current position at Mount Sinai in 2008. Dr. Nestler has been a pioneer in the field of molecular psychiatry, whose research has helped us understand the molecular mechanisms of addiction and depression based on work in animal models.